222 related articles for article (PubMed ID: 15681799)
21. Identification of secondary structure in the 5'-untranslated region of the human adrenomedullin mRNA with implications for the regulation of mRNA translation.
Brenet F; Dussault N; Delfino C; Boudouresque F; Chinot O; Martin PM; Ouafik LH
Oncogene; 2006 Oct; 25(49):6510-9. PubMed ID: 16715138
[TBL] [Abstract][Full Text] [Related]
22. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
[TBL] [Abstract][Full Text] [Related]
23. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.
Dedeoglu A; Cormier K; Payton S; Tseitlin KA; Kremsky JN; Lai L; Li X; Moir RD; Tanzi RE; Bush AI; Kowall NW; Rogers JT; Huang X
Exp Gerontol; 2004; 39(11-12):1641-9. PubMed ID: 15582280
[TBL] [Abstract][Full Text] [Related]
24. Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5'-untranslated region: Implications in Alzheimer's disease.
Long JM; Maloney B; Rogers JT; Lahiri DK
Mol Psychiatry; 2019 Mar; 24(3):345-363. PubMed ID: 30470799
[TBL] [Abstract][Full Text] [Related]
25. Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents.
Mandel S; Amit T; Bar-Am O; Youdim MB
Prog Neurobiol; 2007 Aug; 82(6):348-60. PubMed ID: 17659826
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated region.
Rogers JT; Randall JD; Eder PS; Huang X; Bush AI; Tanzi RE; Venti A; Payton SM; Giordano T; Nagano S; Cahill CM; Moir R; Lahiri DK; Greig N; Sarang SS; Gullans SR
J Mol Neurosci; 2002; 19(1-2):77-82. PubMed ID: 12212798
[TBL] [Abstract][Full Text] [Related]
28. Complex translational regulation of BACE1 involves upstream AUGs and stimulatory elements within the 5' untranslated region.
Mihailovich M; Thermann R; Grohovaz F; Hentze MW; Zacchetti D
Nucleic Acids Res; 2007; 35(9):2975-85. PubMed ID: 17439957
[TBL] [Abstract][Full Text] [Related]
29. Insulin-mediated suppression of apolipoprotein B mRNA translation requires the 5' UTR and is characterized by decreased binding of an insulin-sensitive 110-kDa 5' UTR RNA-binding protein.
Sidiropoulos KG; Pontrelli L; Adeli K
Biochemistry; 2005 Sep; 44(37):12572-81. PubMed ID: 16156669
[TBL] [Abstract][Full Text] [Related]
30. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
Xu X; Sutak R; Richardson DR
Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.
Bandyopadhyay S; Rogers JT
Biochem Pharmacol; 2014 Apr; 88(4):486-94. PubMed ID: 24513321
[TBL] [Abstract][Full Text] [Related]
32. Iron deficiency can upregulate expression of transferrin receptor at both the mRNA and protein level.
Tong X; Kawabata H; Koeffler HP
Br J Haematol; 2002 Feb; 116(2):458-64. PubMed ID: 11841452
[TBL] [Abstract][Full Text] [Related]
33. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
34. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
Chaston TB; Lovejoy DB; Watts RN; Richardson DR
Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
[TBL] [Abstract][Full Text] [Related]
35. Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.
Rogers JT; Bush AI; Cho HH; Smith DH; Thomson AM; Friedlich AL; Lahiri DK; Leedman PJ; Huang X; Cahill CM
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1282-7. PubMed ID: 19021541
[TBL] [Abstract][Full Text] [Related]
36. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters.
Lin HC; Hsieh HM; Chen YH; Hu ML
Neurotoxicology; 2009 Jul; 30(4):622-7. PubMed ID: 19635394
[TBL] [Abstract][Full Text] [Related]
37. Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1.
Cho HH; Cahill CM; Vanderburg CR; Scherzer CR; Wang B; Huang X; Rogers JT
J Biol Chem; 2010 Oct; 285(41):31217-32. PubMed ID: 20558735
[TBL] [Abstract][Full Text] [Related]
38. Repetitive elements in the 5' untranslated region of a human zinc-finger gene modulate transcription and translation efficiency.
Landry JR; Medstrand P; Mager DL
Genomics; 2001 Aug; 76(1-3):110-6. PubMed ID: 11549323
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease.
Avramovich-Tirosh Y; Amit T; Bar-Am O; Zheng H; Fridkin M; Youdim MB
J Neurochem; 2007 Jan; 100(2):490-502. PubMed ID: 17144902
[TBL] [Abstract][Full Text] [Related]
40. A novel beta-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation.
Tanahashi H; Tabira T
Neurosci Lett; 2007 Nov; 428(2-3):103-8. PubMed ID: 17961921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
